PEOPLE - NeoRx makes appointment:
This article was originally published in Clinica
Executive Summary
Wolfgang Oster has been appointed chief operating officer at NeoRx (Seattle),a developer of innovative products designed to provide improved treatments for patients with cancer. Mr Oster will be responsible for worldwide research, development, medical regulatory, manufacturing and quality assurance.